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Introduction
Oxaliplatin (OxPt) is a third generation chemotherapeutic drug used in the treatment of colorectal cancer and cisplatin resistant cancers, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] it was developed to overcome the nephrotoxicity of cisplatin and myelosuppression with carboplatin treatment. [14] Oxaliplatin has a broader range of activity than cisplatin and increased cytotoxicity over cis and carboplatin due to increased inhibition of DNA synthesis and greater efficiency in DNA repair. [13, 15, 16] The amine groups of cisplatin are replaced by diaminocyclohexane (dach) to form [Pt(dach)oxalate], oxaliplatin. The dach ligand is not recognised by mismatch repair complexes, which may explain its effectiveness in the treatment of cisplatin and carboplatin resistant cancers. [15] The transport and interactions of oxaliplatin within cells is still not fully understood however,the simplistic route from blood to nuclear DNA involves the passive diffusion of oxaliplatin into the cell from the extracellular fluid where the Cl -concentration is high (> 100 mM) into the cytoplasm, where the Cl -concentration is low (4-20 mM [11, 13] , shown in Figure 1 and can interact with a plethora of non-DNA ligands. Based on previous work by Zayed et. al. [18] we can assume that the majority of the administered drug is found in the cell cytosol. It is thought that the most likely sites for oxaliplatin interaction are the thiol groups of intercellular peptides and proteins. Recent studies have shown that the activated form of oxaliplatin forms very stable complexes with glutathione, being the most abundant low molecular weight thiol containing molecule in human cells. [19] [20] [21] However, work by this group [21, 22] and elsewhere [22, 23] suggests that Pt binding to intercellular peptides through their terminal amino nitrogen atoms and carbonyl oxygen atoms are possible and energetically competitive to sulphur attachment. This in combination with the large excess of these binding sites over those of sulphur raises the possibility of Pt adduction to non-thiol containing ligands in the proteome.
All such non-DNA interactions are responsible for chemo-resistance and many of the side effects; including sensory-motor neuropathy, myelosuppression, gastrointestinal toxicity, idiosyncratic and hypersensitivity reactions. [24] The endogenous dipeptide L-carnosine (β-alanyl-L-histidine) was discovered by Gulewitsch and Amiradzibi [25] from muscle tissue extracts in 1900 [26, 27] and is found in several organs including the brain (olfactory bulb and hippocampus) [28] , cardiac muscle, kidney and stomach. [29, 30] In the skeletal muscle and nerve cells it is found at concentrations of up to 20 mM. [31, 32] Since its discovery there have been many investigations into its biological function and it is now known that carnosine acts as an anti-oxidant, scavenger of free radicals and active oxygen species [30] , as a biological buffer, a source for histidine, an immunostimulant and transition metal ion chelator, especially for Zn 2+ and Cu 2+ [33] and heavy metals. [34] The ability of carnosine to bind Zn 2+ helps modulate neuronal excitability by preventing the Zn 2+ inhibition of neurotransmitter receptors. [35] Carnosine is also effective in the prevention and partial reversal of cataracts [36] and in the treatment of Wilsons disease [37] and Alzheimers due to its metal chelating and free radical scavenging ability and also acting as a β-amyloid toxicity inhibitor. [35, 38] It has also been shown that carnosine acts as a neuroprotector [39, 40] and can retard tumour growth in mouse models. [41] More recently it has been reported that carnosine can prevent cell proliferation in colon cancer cells. [47, 48] The related dipeptides N-acetlycarnosine and anserine share many of the beneficial characteristics of carnosine. The N-acetyled form of carnosine, N-acetyl-carnosine has been
shown to be effective in the treatment of stomach ulcers [42] and similarly to carnosine has been used in the treatment of cataracts. [43, 44] Anserine on the other hand, acts a chelator for copper and as an antioxidant as well as enhances the anti-tumour activity of doxorubicin.
[45] Due to its presence in high abundance in the cytosolic fractions of cells [30] and its ability to scavenge transition metal elements we believe that the interactions between carnosine and oxaliplatin are of important scientific value. The investigation of the coordination chemistry of carnosine and oxaliplatin may provide new understanding in the mechanism of the cellular response to these drugs. for a wide range of Pt adducts to exist within the cell rather than specific Pt targets is a possible scenario. The interactions of carnosine and the related dipeptides anserine and Nacetylcarnosine with Oxaliplatin are therefore of great interest. By using a simple highly abundant dipeptide, such as carnosine to act as a simplified model of the broader Ptmeallome, we present detailed structural analysis of carnosine and the hydrolysed forms of oxaliplatin.
Instrumentation
An LTQ linear ion trap mass spectrometer with an electrospray source and a high resolution Q-Exactive Fourier transform mass spectrometer (Thermo Electron, San Jose, CA, USA)
were used. Both instruments were calibrated using Ultramark ® 1621, caffeine and Met-ArgPhe-Ala (MFRA) in accordance with the manufacturer's recommendations. The Q-Exactive was equipped with a Tri Versa NanoMate ESI chip nanospray (Advion, New York, USA).
For the LTQ Resolving powers achieved were in the order of 1500 while the upper instrumental error limit in measurements was 0.2 m/z units. The LTQ auto-tune routine was used to obtain lens, quadrupole and octapole voltages for maximum transmission of the ions of interest. Helium gas, admitted into the ion trap at a maintained pressure of approximately 10 -3 Torr, was used as the buffer gas to improve the trapping efficiency andas the collision gas for collision-induced dissociation (CID) experiments performed here at 15 eV in the lab frame. Experiments designed to elucidate ion structures or fragmentation pathways on the LTQ were performed as follows: the ion of interest was selected then collisionally activated by setting the activation amplitude at 25-35% of the maximum voltage available (determined empirically), and the activation Q setting (used to adjust the frequency of the RF excitation voltage) was set at 0.25 units. Sample solutions were continuously infused at a flow rate of 5 µl min -1 into the pneumatically assisted electrospray probe using dry nitrogen as the nebulising gas. Auxiliary and sheath gases were tuned daily for maximum signal transmission. Two tandem quadrupole mass spectrometers, An Acquity TQ and A XEVO TQ (Waters, MA, USA) both equipped with electrospray ionisation interface were also used in this work. Both triple quadrupoles were operated in positive ion mode, with typical values of cone, capillary and extractor voltages set to 30, 2500, and 3 respectively. The desolvation gas was usually set at a flow of 250 L h −1 and a temperature of 150 ºC. Argon was used as the collision gas at a typical flow rate of 0.15 ml min -1 . Tandem mass spectra were obtained at collision energies in the range 5-25 eV in the lab frame having both Q1 and Q3 operated at unit resolution with typical a dwell time of 25 millisecond per transition.
Reagents
Carnosine, Anserine, HPLC-grade water and methanol were all purchased from SigmaAldrich, UK. N-Acetyl carnosine was purchased from Nanjing Gemsen international, China while oxaliplatin was obtained from Sanofi-Synthelabo Limited (Guildford, UK).
In Vitro cell viability assays
To determine the in vitro effect of carnosine, the hepatocellular carcinoma cell line HepG2 was exposed to varying concentrations of OxPt, as well as several solution mixtures of OxPt and carnosine. The viability of HepG2 was assessed through MTT assay, which utilizes the conversion of the tetrazolium salt MTT (dimethylthiazol diphenyl tetrazolium bromide purchased from Serva, Germany) to formazan by dehydrogenase enzymes in living cells. [49] In brief, cells were cultured in 96-well plate (30,000 cells/well) at 37 ºC humidified with 5% µl MTT (5 mg/ml) and 100 µl fresh media were added to each well and incubated for 3 hours, all media was then discarded, and the purple formazan crystals formed were solubilized via the addition of 100 µl DMSO (Sigma-Aldrich, USA). The absorbance of each well was measured at 595 nm using a microplate reader FLUOstar OPTIMA (BMG LabTech, Germany). Cell viability was determined by calculating the absorbance of the test wells as a percentage of the control wells.
Results and discussion
HepG2 cells showed decreased viability with exposure to increased concentrations of OxPt as shown in Figure 1 . The most significant changes in cell viability were observed at exposure to OxPt concentrations of 16 μg ml -1 and greater as indicated by P values < 0.00001. To examine the in vitro effect of carnosine on OxPt cytotoxicity, several solutions were prepared at a fixed OxPt concentration of 24 μg ml -1 while varying the molar equivalent of carnosine.
While the choice of OxPt concentration in these experiments was arbitrary, a value was chosen that corresponds to relatively low cell viability in order to easily observe the effects of subsequent addition of carnosine. It is also important to note that the OxPt concentration value chosen for these set of experiments was one that brought the most statistically significant decrease in the viability of the treated HepG2 cells as indicated by P values < 0.00001 (see Figure 1) . The results of these experiments is shown in Figure 2 which points to a positive correlation between cell viability and increasing molar equivalence of canosine relative to OxPt. These differences were much less pronounced past the initial incremental addition of carnosine where a significant increase in cell viability was shown due to the exposure of a 1:1 molar ratio of carnosine to Oxpt relative to cells only exposed to OxPt at the same concentration and for the same incubation time. This was shown to be statistically significant with P value < 0.00001 at all non-zero molar ratios of carnosine to OxPt used.
This result suggests that carnosine can interact with the OxPt drug forming complexes that reduce the drug's action.
In order to investigate the ability of carnosine to be passively diffused through cells, the same set of experiments were repeated but now cells were first incubated for 24 hours with carnosine at various concentrations. After this incubation period, the media containing carnosine was discarded and fresh media containing 24 μg ml -1 of OxPt were added and allowed to incubate with the cells for a further 24 hour period. The results of these last set of in vitro experiment shown in Figure 3 indicate slight increased cell viability upon the exposure to carnosine. The much less pronounced effect shown in Figure 3 relative to that shown in Figure 2 is most likely due to the inability of carnosine to effectively passively diffuse through the cells. This also suggests that the process is kinetically controlled and is consistent with the near constant cell viability data obtained whenever the carnosine was present irrespective of the concentration at which it was allowed to incubate with the cells. (also see Figure S1 ), 5 (also see Figure S2 ), and 6.
The assignments of these ions were confirmed by comparing the observed isotopic patterns to The precursor ion [Carnosine + OxPt + H] + were theoretically examined in great detail in the gas phase and in solution as this complex is most likely formed initially in the solution mixture used here. The potential energy surfaces of this complex in the gas phase and in solution were found to be relatively flat with several low lying minima as listed in Table 1 and shown in This is consistent with an earlier study examining the silver ion binding energies of all 20 α-amino acids, showing that histidine had the third highest silver ion binding energy being lower than that of arginine and only slightly lower than that of lysine.
[53] The lowest energy conformer of the Ag + -histidine complex in that perious study also showed Pt-coordination to the pros nitrogen atoms of the histidine ring. [53] Here, the global minimum on the gas phase potential energy surface is structure 1A as shown in Figure 10 , this structure is internally stabilised by four strong hydrogen bonds making it 3.4 kcal mol -1 lower in energy in the gas phase relative to 1D and only 0.8 kcal mol -1 removed from the lowest energy structure calculated on the solution phase potential energy surface being structure 1D as shown in Figure 10 . Structure 1D is also stabilised by two internal hydrogen bonds. It is interesting to note that in the gas phase structure 1A the hydrogen bond between one of the NH hydrogen atoms of the dach ligand and the carboxylic oxygen of the terminal carboxylate group being at 1.886 Å becomes none existent in solution (distance of 5.297 Å as shown in Figure 10 ) as it is replaced by external solvation. The strongest hydrogen bonds in either the two gas phase structures, 1A and 1D, is between each of the hydrogen atoms of the protonated oxalate moieties and their respective terminal amino nitrogen atom of each of the carnosine dipeptides. This is determined based on the shortest hydrogen bonding distance calculated in either gas phase structure being 1.315 and 1.328 Å for structures 1A and 1D respectively as well as on the resulting hydrogen bonding angles being closest to the ideal linear arrangement calculated to be 166º for the N-H-O in both cases.
In the solution phase on the other hand structures 1A and 1D both have their terminal amino nitrogen atoms protonated while forming strong hydrogen bonds to a carboxylic oxygen atom of the oxalate moiety in each case at 1.509 and 1.496 Å respectively. If the solution phase structures 1A or 1D being the two lowest energy structures on that potential energy surface are transferred to the gas phase by solvent evaporation through the soft electrospray ionisation technique while maintaining the protonation on the terminal amino nitrogen atom a structure 1K or 1I would result, this structure is similar to 1C with the noted difference that structure 1C involves Pt coordination to the tele nitrogen of the histidine ring. Structure 1K is calculated to be energetically competitive in the gas phase and in solution being only 8.7
and 2.7 kcal mol -1 removed from either global minina respectively. Alternatively, the gasphase transfer of the hydrogen atom of the protonated oxalate moiety to the terminal amino nitrogen atom in either gas phase structure 1A or 1D while maintaining the Pt coordination to the pros nitrogen of histidine would also results in the formation of structure 1K or 1I. The loss of CO 2 from the deprotonated oxalate moiety of this resulting structure, 1K or 1I, and 5.9 kcal mol -1 higher in free energy relative to structure 2A respectively. The gas phase inter-conversion between these three structures is expected to be rapid and well within the energies available under the collision induced dissociation conditions employed here as they involve simple rotations about single bonds. Interestingly, structure 2C involves a hydrogen bond at 1.765 Å between the OH hydrogen of the carboxylate group of the carnosine dipeptide and the Pt-bound oxygen atom of the remaining HCO 2 group of the oxalate moiety.
The transfer of this hydrogen atom from the OH group to the carboxylate group of carnosine followed by the neutral loss of the resulting H 2 CO 2 group and the subsequent binding of the resulting carboxylic oxygen to the Pt center results in structure 3A shown in Figure 13 .
Structure 3A is calculated to be the lowest structure for the [Carnosine -H + Pt(dach)] + species assigned as the cluster centered on mz/534 in Figure 7 and the signals at m/z 533, 534
and 535 in panels A, B and D respectively in Figure S5 The two other signals observed at significantly lower intensities in Figure S7 being the lowest energy species on this surface as shown in Figure 14 .
Conclusions
In this paper, in vitro studies on hepatocellular carcinoma HepG2 cells suggest that the dipeptide carnosine may inhibit the cytotoxic action of OxPt most likely through the formation of complexes that are less cytotoxic than OxPt alone. Evidence was provided to suggest that pre-exposure of HepG2 cells to elevated levels of carnosine appears to have a lasting effect on reducing the cytotoxicity of OxPt even after the removal of the carnosine.
This effect, however, was shown to be under kinetic control as its magnitude was shown not to vary significantly with the level of carnosine exposure within the concentration range used in this study. Various mass spectrometry techniques employing electrospray ionization and chip nanospray were employed to study the interaction of oxaliplatin with the naturally
abundant cytoplasmic dipeptide ligand β-alanyl-L-histidine (carnosine) as well as two of its derivatives being β-alanyl-N-methylhistidine (anserine) and N-Acetylcarnosine (NAC).
Evidence of complexation between OxPt and each of the three ligands examined is presented.
Most species observed were unambiguously assigned and compared to their theoretical isotopic patterns. 
